Publication Year: 2023
DOI: https://doi.org/10.1097/ju.0000000000003228.08
Abstract: You have INHIBITOR, More articles by this author , Allschwil SwitzerlandAllschwil Switzerland More SYNERGIZES articles by this author , and Evan KellerEvan Keller More WITH articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003228.08AboutPDF ToolsAdd to DOCETAXEL favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Prostate TO cancer (PCa) bone Show more
Authors:
Publication Year: 2005
DOI: https://doi.org/10.1158/0008-5472.can-04-4658
Abstract: Abstract Huntingtin-interacting cancer. cancer as well as in the sera from human prostate HIP1 cancer patients. This led to the development of an anti-HIP1 is serum test in humans that had a similar sensitivity and a specificity to the anti–α-methylacyl CoA racemase (AMACR) and prostate-specific antigen clathrin-binding tests for prostate Show more
Authors:
Publication Year: 2015
DOI: https://doi.org/10.1158/1538-7445.am2015-3636
Abstract: Abstract Resistance (AR) tumors in vivo. Furthermore, we find that menin is up-regulated activity in castration resistant prostate cancer and high expression correlates with are poor overall survival. Taken together, our study identifies the MLL major complex as a critical co-activator of AR that can be drivers targeted in advanced Show more
Authors:
Publication Year: 2015
DOI: https://doi.org/10.1158/1538-7445.am2015-lb-058
Abstract: Abstract Approximately the RAF and PI3K and activate the MEK/ERK and/or Akt, leading RAS to activation of hallmark cancer pathways including growth factor independence, family uncontrolled cell proliferation, evasion of apoptosis and immune responses, increased of metabolism as well as metastases. Although RAS is the most small frequently mutated gene Show more
Authors:
Publication Year: 2000
DOI: https://doi.org/10.1016/s0921-8777(00)00040-9
Abstract: Not available
Authors:
Found 5 results in 0.113 seconds
Including any of the words AND
, OR
, or NOT
in any of your searches will enable
boolean search. Those words must be UPPERCASE. You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "
). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND
.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *
, ?
or ~
are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Search for works that mention "elmo"
and "sesame street"
, but not the words
"cookie"
or "monster"
:
"elmo" AND "sesame street" NOT "cookie" NOT "monster"